Αποτελέσματα Αναζήτησης
Download Medicare Reimbursement Guide. If you have questions related to Cardiolite ® reimbursement, please call (800) 362-2668 (Option 3) or email reimbursement@lantheus.com. Lantheus cannot guarantee coverage or payment for products or procedures.
- Two Day Stress/Rest
Begin exercise stress scan 10–20 minutes after Cardiolite ®...
- Risk Stratification
*Based on a prospective study of 5,807 consecutive patients,...
- Imaging Protocols
Imaging Protocols. Suggested Cardiolite ® One-Day...
- Prescribing Information
INDICATIONS AND USAGE FOR CARDIOLITE ®: Myocardial Imaging:...
- Perfusion and Function
Myocardial Perfusion and Function assessed by a Gated...
- Patients
INDICATIONS AND USAGE FOR CARDIOLITE ®: Myocardial Imaging:...
- Two Day Stress/Rest
CARDIOLITE® is a myocardial perfusion agent indicated for: detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) evaluating myocardial function and developing information for use in patient management decisions.
Medical Billing Training Manual - Free download as Word Doc (.doc), PDF File (.pdf), Text File (.txt) or read online for free. Scribd is the world's largest social reading and publishing site.
A Cardiolite treadmill stress test is an exercise test that is helpful in detecting the presence of coronary artery disease. Coronary artery disease occurs when the heart’s vessels become partially blocked or narrowed by the build-up of fatty materials preventing the heart from receiving the blood it needs to function properly.
CPT® 2024 Professional Edition is the definitive AMA-authored resource to help healthcare professionals correctly report and bill medical procedures and services. Only the AMA, with the help of physicians and other experts in the healthcare community, creates and maintains the CPT® code set.
Download free Adobe Acrobat Reader software for your Windows, Mac OS and Android devices to view, print, and comment on PDF documents.
CARDIOLITE® is a myocardial perfusion agent indicated for: detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) evaluating myocardial function and developing information for use in patient management decisions.